Bazan, Vanessa Marie
Taylor, Evan Michael
Gunn, Tyler Michael
Zwischenberger, Joseph Bertram
Article History
Received: 9 December 2019
Revised: 25 January 2020
Accepted: 28 January 2020
First Online: 31 March 2020
Compliance with ethical standards
:
: Dr. Zwischenberger has the following to disclose: he receives royalties for a patent licensed to Avalon/Maquet for the Avalon Elite double lumen cannula, he is the recipient of grant funding from the NIH, he is a consultant on the Cytosorbents, Inc. Cardiac Advisory Board, and he is a partner in WZ-Biotech. Vanessa M. Bazan has nothing to disclose. Evan M. Taylor has nothing to disclose. Dr. Gunn has nothing to disclose.
: No funding was received for this review article
: Not Required for a Review Article
: Not Required for a Review Article
: Not Required for a Review Article